HUMA stock moved 4.6% higher in pre-market trading on January 28, 2022, after the company reported positive animal trial data on its HAV product. Humacyte
Read more
HUMA stock moved 4.6% higher in pre-market trading on January 28, 2022, after the company reported positive animal trial data on its HAV product. Humacyte
Read moreARDS stock got a bullish commentary from H.C. Wainwright following the revelation that the company received money from the Bill and Melinda Gates Foundation. H.C.
Read morePFE stock rose in pre-market trading on January 27, 2022, after the company received a positive CHMP opinion for its COVID-19 pill. Pfizer Receives CHMP
Read moreThe penny stock BVXV has exploded more than 16% higher in early trading on January 26, 2022, after Aegis initiated coverage of the stock with
Read moreCathie Wood’s ARK Investment bought 967K shares of Ginkgo Bioworks on January 25, 2022. Ginkgo Bioworks Announces Acquisition of Massachusetts COVID-19 Testing Provider Project Beacon
Read more